True Wealth Design
AURA icon

True Wealth Design’s Aura Biosciences AURA Stock Holding History

True Wealth Design’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$465 Sell
74
-13
-15% -$93 ﹤0.01% 2151
2026
Q2 		$618 Buy
87
+73
+521% +$522 ﹤0.01% 2128
2026
Q1 		$94 Buy
+14
New +$80 ﹤0.01% 2484
2025
Q2 		– Sell
-36
Closed -$211 – 2589
2025
Q1 		$211 Buy
+36
New +$272 ﹤0.01% 1928

Other funds holding AURA

Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Levin Capital Strategies
Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Regency Capital Management
Regency Capital Management Honolulu, Hawaii $247M AUM 24.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

True Wealth Design's AURA Position: Q3 2026 in Review

True Wealth Design reduced its Aura Biosciences (AURA) stake by 15% in Q3 2026, selling an estimated $93 and leaving 74 shares worth $465. The position accounts for ﹤0.01% of the portfolio, ranked #2151.

True Wealth Design first reported a position in AURA in Q1 2025 and has held it in 4 quarters since. The position peaked at $618 in Q2 2026. 62 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • True Wealth Design held 74 shares of Aura Biosciences worth $465 as of Q3 2026.
  • True Wealth Design sold 13 Aura Biosciences shares in Q3 2026, an estimated $93.
  • Aura Biosciences made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2151 holding.
  • True Wealth Design first reported a position in Aura Biosciences in Q1 2025 and has held it in 4 quarters since.
  • True Wealth Design's Aura Biosciences position peaked at $618 in Q2 2026.
  • 62 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.